gefitinib has been researched along with corticosterone in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (corticosterone) | Trials (corticosterone) | Recent Studies (post-2010) (corticosterone) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 27,121 | 124 | 6,622 |
| Protein | Taxonomy | gefitinib (IC50) | corticosterone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 3 | Homo sapiens (human) | 0.945 | |
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | 4.9 | |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 4.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Shlomo, A; Bruyette, D; Cooper, O; Fukuoka, H; Mamelak, A; Melmed, S; Ren, SG | 1 |
1 other study(ies) available for gefitinib and corticosterone
| Article | Year |
|---|---|
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Animals; Cell Line, Tumor; Corticosterone; Dog Diseases; Dogs; Drug Screening Assays, Antitumor; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Neoplasm Transplantation; Pituitary ACTH Hypersecretion; Pro-Opiomelanocortin; Promoter Regions, Genetic; Protein Kinase Inhibitors; Quinazolines; Secretory Rate; Tumor Burden | 2011 |